SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Meta Platforms, Inc. engages in the development of social media applications. It builds technology that helps people connect and share, find communities, and grow businesses. It operates through the Family of Apps (FoA) and Reality Labs (RL) segments. The FoA segment consists of Facebook, Instagram, Messenger, WhatsApp, and other services. The RL segment includes augmented, mixed and virtual reality related consumer hardware, software, and content. The company was founded by Mark Elliot Zuckerberg, Dustin Moskovitz, Chris R. Hughes, Andrew McCollum, and Eduardo P. Saverin on February 4, 2004, and is headquartered in Menlo Park, CA.

Meta Platforms Inc - Ordinary Shares - Class A

Meta Platforms Inc

Meta Platforms is facing intense downward pressure driven by a combination of broader market volatility, sector-wide rotation out of mega-cap tech, and investor anxiety following recent legal rulings regarding addictive product design. While some in the community are panic-selling and calling for further declines, many retail participants are debating whether these developments represent a long-term structural threat to the companys business model or a temporary overreaction providing a lucrative buying opportunity.

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+, and TMTG News. It operates through the Media and Truth.Fi segments. The Media segment includes products and services such as advertisement through the Truth Social platform. The Truth.Fi segment relates to customized exchange-traded funds or exchange-traded products invested in America First principles, and bitcoin and similar cryptocurrencies or crypto-related securities. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

DJT is facing intense volatility as market participants react to escalating geopolitical tensions and erratic messaging surrounding potential military actions in the Middle East. The community is actively debating the stock's stability amidst heavy skepticism regarding official communications, with many users focusing on the broader impact of administration policies on both their portfolios and the global economy.

Unity Software, Inc. engages in the developing video gaming software. It also provides software solutions to create, run and monetize interactive, real-time two-dimensional and three-dimensional content for mobile phones, tablets, consoles, and augmented and virtual reality devices. Its platform is used by developers, artists, and designers to build content for gaming, film, retail, automotive, architecture, engineering, and construction industries. The company was founded by Joachim Ante and David Helgason in 2004 and is headquartered in San Francisco, CA.

Unity Software Inc

Unity Software is drawing significant attention after reporting preliminary Q1 financial results that exceeded guidance and revealing plans to wind down its non-core ironSource Ads Network to focus on higher-growth segments like Unity Vector. While some investors are expressing optimism about a potential bottom and long-term recovery fueled by AI integration and strategic cost-cutting, others remain wary of the stock's persistent volatility and the broader sector-wide headwinds affecting software valuations.

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is currently experiencing significant volatility as investors weigh the company's ambitious autonomous and robotics growth narrative against mounting regulatory scrutiny over its FSD technology and broader macroeconomic pressure from regional conflict. Market participants are actively debating the potential impact of a possible SpaceX IPO and the reliability of Tesla's future product promises, leading to intense speculation among both retail and institutional traders regarding the stock's near-term direction.

Kodiak Sciences, Inc. is a clinical-stage biopharmaceutical company, which engages in the research, development, and commercialization of therapeutics for retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA.

Kodiak Sciences Inc

Kodiak Sciences is trending as investors digest positive topline results from the GLOW2 Phase 3 study, which met primary and secondary endpoints for treating diabetic retinopathy. The community is actively debating the company's regulatory path and potential for a short squeeze, while highlighting the significance of the clinical data in de-risking the pipeline and reigniting interest in its long-acting therapeutic platform.

Greenland Energy Co.

Greenland Energy Company (GLND) is trending following its recent business combination and the appointment of former TD Ameritrade CEO Joe Moglia as an executive advisor. The community is actively discussing the company's potential to unlock massive oil reserves in the Jameson Land Basin, with many traders drawing parallels to other energy sector plays and highlighting the involvement of major industry partners like Halliburton.

Wave Life Sciences Ltd. is a clinical-stage biotechnology company, which focuses on developing its proprietary RNA medicines platform and PRISM. It also develop and commercialize a pipeline RNA medicines in a variety of therapeutic areas. The company was founded by Gregory L. Verdine and Takeshi Wada on July 23, 2012 and is headquartered in Singapore.

Wave Life Sciences Ltd.

Wave Life Sciences Ltd

Wave Life Sciences is trending due to positive interim Phase 1 data for its obesity candidate WVE-007, which demonstrated promising visceral fat reduction and lean muscle preservation. The community is actively debating the trial's methodology regarding patient BMI while weighing the stock's significant volatility against a growing consensus of bullish analyst sentiment and potential long-term value in the obesity treatment space.

On Holding AG engages in the development and distribution of sports products such as footwear, apparel, and accessories for high-performance running, outdoor, all-day activities, and tennis. It sells its products worldwide through independent retailers and global distributors, its own online presence, and its own stores. The company was founded by David Allemann, Olivier Bernhard, and Caspar Coppetti in January 2010 and is headquartered in Zurich, Switzerland.

On Holding AG - Ordinary Shares Class A

On Holding AG

On Holding is experiencing intense volatility and downward pressure as investors rotate out of consumer apparel and footwear stocks amid tariff concerns and shifting growth expectations. Despite the sell-off, the community remains deeply divided, with many bulls highlighting robust brand momentum, consistent earnings beats, and successful market share gains against industry giants as reasons to accumulate on the dip.

Akamai Technologies, Inc. engages in the provision of cloud services for delivering, optimizing, and securing content and business applications over the Internet. Its products include security, web performance, media delivery, and network operator. The company was founded by Frank T. Leighton, Jonathan Seelig, Randall S. Kaplan, and Daniel M. Lewin on August 20, 1998 and is headquartered in Cambridge, MA.

Akamai Technologies Inc

Akamai is currently trending as investors focus on the company's strategic pivot toward edge computing and AI-driven cybersecurity infrastructure. Community discussion is heavily centered on the company's partnership with NVIDIA and its potential to capture long-term structural opportunities in AI inferencing, despite recent volatility driven by earnings guidance and broader sector-wide macro pressures.

Reddit, Inc. operates an entertainment, social networking, and news website where registered community members can submit content. The firm provides online news services where users can select and rank web content. It also offers a personalized filter on the day's story, using previous votes to determine what new things the user might like to read. The company was founded by Steven Ladd Huffman and Alexis Ohanian on June 23, 2005 and is headquartered in San Francisco, CA.

Reddit Inc. - Ordinary Shares - Class A

Reddit Inc

Reddit is seeing increased investor attention as the company enters a strategic ad partnership with Pacvue, aimed at expanding its enterprise-scale advertising capabilities. While the community remains divided over management's stock sales and the platform's long-term monetization potential, many traders are closely watching how the stock recovers from recent volatility.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Elon Musk's X Loses Advertiser Boycott Lawsuit As 'Teflon Elon' Legal Streak Unravels

Judge Boyle throws out Elon Musk's antitrust lawsuit against WFA, Nestle, Shell, Mars, CVS, and Colgate-Palmolive. X Corp failed to prove harm.read more...

Peak Financial Advisors LLC Acquires 19,298 Shares of CVS Health Corporation $CVS

Peak Financial Advisors LLC raised its holdings in CVS Health Corporation (NYSE:CVS - Free Report) by 105.9% during the fourth quarter, according to the company in its most recent 13F filing with the...

Dr. Oz warns foreign nationals may be tied to US hospice fraud, points to LA as hotspot

Networks of foreign nationals may be linked to U.S. hospice fraud, Centers for Medicare & Medicaid Services Administrator Dr. Mehmet Oz warned Wednesday in a FOX Business special, pointing to one major city as a key area of concern."You have to ask yourself exactly how many people are actually...

Is BrightSpring BTSG Stock Expensive at 24.5x Forward P/E?

BTSG trades at 24.5x forward earnings after strong 2025 results, but 2026 hinges on margin gains offsetting policy-driven revenue headwinds.

BTSG Growth Drivers in 2026 Across Specialty and Providers

BTSG leans on specialty and provider growth in 2026, with margin expansion expected to outpace revenue despite near-term pharmacy headwinds.

SG Americas Securities LLC Acquires 1,015,775 Shares of CVS Health Corporation $CVS

SG Americas Securities LLC grew its stake in shares of CVS Health Corporation (NYSE:CVS - Free Report) by 1,575.7% during the 4th quarter, according to the company in its most recent Form 13F filing...

Mark Cuban Calls $30,000 Corporate Healthcare Burden 'Insane,' Backs Bill To Break Up Big Medicine Giants UNH, CVS, CI

Mark Cuban calls $30K corporate healthcare costs 'insane,' backing a new bill to break up big medicine giants like UNH, CVS, and CI.read more...

<ul class="summary-bullets"><li>Sources told Reuters that the deal is modeled on a similar agreement inked between FTC and Cigna’s pharmacy benefit manager Express Scripts.</li><li>Leerink said the report that CVS Health has likely reached a proposed settlement with the FTC isn't a “major surprise.”</li></ul><p>Shares of CVS Health (CVS) closed 2% higher on Tuesday on the heels of a report that the company has reached a proposed settlement with the Federal Trade Commission ​on insulin pricing.</p><p>As per a report from Reuters News, the final terms of the deal are still pending and will be confirmed once it is officially finalized. As per the report, the company expects the settlement process to conclude in the coming weeks.</p><p>Sources <a class="st-link-external" target="_blank" rel="noopener noreferrer nofollow" href="https://www.reuters.com/legal/litigation/cvs-reaches-insulin-pricing-settlement-with-ftc-2026-03-24/">told</a> Reuters that the deal is modeled on a similar agreement inked between FTC and Cigna’s pharmacy benefit manager Express Scripts. The deal between the two companies could be signed into effect earlier than two weeks, the report added.</p><p>FTC sued Express Scripts, UnitedHealth’s Optum and CVS’s Caremark in 2024, alleging they deliberately excluded lower-cost insulin to favor higher-rebate, high-price products in list of drugs covered by insurers.</p><h2 class="st-heading-2">Leerink Chimes In</h2><p>Leerink said the report that CVS Health has likely reached a proposed settlement with the FTC isn't a “major surprise.” However, the firm added that completing any settlement is an incremental positive as it removes an "air of uncertainty" from a pharmacy benefit management business that has had numerous recent overhangs.</p><p>Leerink reiterated an ‘Outperform’ rating and $98 price target on CVS Health shares. The price target represents a potential upside of about 35% from the stock’s closing price on Tuesday.</p><h2 class="st-heading-2">Express Scripts Settlement</h2><p>Cigna’s Express Scripts reached a landmark settlement last month with the FTC to resolve allegations that its anticompetitive rebating practices artificially inflated insulin list prices. The deal required Express Script to adopt fundamental changes to its business practices in favor of transparency and delink manufacturer compensation from drug prices, thereby bringing down cost for patients.</p><p>The settlement is expected to bring down patients’ out-of-pocket costs for drugs like insulin by up to $7 billion over 10 years, FTC then said.</p><h2 class="st-heading-2">How Did Stocktwits Users React?</h2><p>On Stocktwits, retail sentiment around CVS rose from ‘neutral’ to ‘bullish’ territory over the past 24 hours, while message volume remained at ‘normal’ levels.</p><p><a href="https://stocktwits.com/symbol/CVS">CVS stock</a> has gained 8% over the past 12 months.&nbsp;</p><p>Read More: <a href="https://stocktwits.com/news-articles/markets/equity/us-markets-rally-after-hours-on-optimism-for-end-to-middle-east-tensions/cZ3nx5mRI1N">US Markets Rally After Hours On Optimism For An End To Middle East Tensions</a></p><p><i>For updates and corrections, email newsroom[at]stocktwits[dot]com.</i></p>

In this photo illustration, the logo of CVS Health Corporation is displayed on a smartphone screen, with the company's red heart branding visible in the background. (Photo illustration by Cheng Xin/Getty Images)

Wall Street Weighs In On FTC-CVS Health Proposed Settlement: Not Major Surprise But Removes Air Of Uncertainty

As per a report from Reuters News, the final terms of the settlement deal are still pending and will be confirmed once it is officially finalized.

Equity

As per a report from Reuters News, the final terms of the settlement deal are still pending and will be confirmed once it is officially finalized.


CVS Health (CVS) Ascends While Market Falls: Some Facts to Note

CVS Health (CVS) concluded the recent trading session at $72.8, signifying a +2.12% move from its prior day's close.

CVS reaches insulin pricing settlement with FTC

Pharmacy benefit managers, which set how drugs are covered by health insurance, have faced scrutiny from regulators and lawmakers over pricing practices...

CVS Health Corp. is a health solutions company, which engages in the provision of healthcare services. It operates through the following segments: Health Care Benefits, Health Services, Pharmacy and Consumer Wellness, and Corporate and Other. The Health Care Benefits segment operates as a health care benefits provider. The Health Services segment offers a full range of PBM solutions, delivers health care services in its medical clinics, virtually, and in the home. The Pharmacy & Consumer Wellness segment dispenses prescriptions in its retail pharmacies and through its infusion operations. The Corporate and Other Segment is involved in management and administrative expenses. The company was founded by Stanley P. Goldstein and Ralph Hoagland in 1963 and is headquartered in Woonsocket, RI.

CVS Health Corp

Alphabet $GOOGL

Robinhood $HOOD

Rocket Lab $RKLB

Sandisk $SNDK

The ticker that owned the conversation. This award honors the stock that defined the market narrative through engagement, price action, and cultural presence on the boards.

CVS
CVS Health Corp

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest CVS News

CVSCVS Health Corp